The Australian National Phenome Centre is Australia’s first metabolic phenotyping centre capable of high throughput screening of human clinical samples. It was created as part of the Western Australian Health Translation Network (WAHTN), a partnership of several universities (including all five WA universities) and health institutes, both in Australia and overseas. It is a member of the International Phenome Centre Network.
Metabolic phenotyping provides a detailed analysis of the metabolic state of an organism, its genetics and environmental contributions. This enables scientists to examine the interactions between genes, environments, microbiomes, diets and lifestyles and their impact on health and disease. Its ultimate objective is to generate global metabolomics atlases of diseases for the clinical as well as broader life sciences, including animal, plant and environmental sciences.
The Centre incorporates a dedicated agricultural platform used to understand crop disease and disease management at a systems scale, test for trace chemical contaminants in the food chain, and monitor the impact of climate change on productivity.
The Antimicrobial Resistance and Infectious Diseases (AMRID) Research Laboratory is a $3.5 million One Health research and antimicrobial resistance surveillance facility.
It has a suite of state-of-the-art molecular and non-molecular technologies, including high throughput genome sequencing, next-generation robotics platforms for drug discovery and antimicrobial resistance research, and MALDI-TOF mass spectrometry for rapid identification of human and animal pathogens.
It is the only reference laboratory in Australia carrying out disease surveillance that covers the emergence of antimicrobial resistance in both humans and animals.
Dr Sam Abraham
+61 8 9360 2054
The Enabling Technologies Centre supports omics facilities, including high throughput sequencing; structural, comparative and functional genomics; transgenics; small scale metabolomics; supported by biostatistics and bioinformatics services.
Sequencing capacity includes whole genome analysis of viruses, bacteria and targeted regions of the human genome. We can also provide proprietary software for the analysis of the copious and complex raw data arising from second generation sequencing platforms.
These platforms are located within quarantine-accredited laboratory facilities. We offer rigorous sample handling and tracking processes, our instruments benefit from a quality and management framework, and using automated robotic platforms we achieve efficiency, reliability and reproducible results.
The Centre can host industry and academic partners for periods of weeks to years, offering these facilities in combination with the largest on-campus research farm in the southern hemisphere for field experiments.
Associate Professor Mark Watson
+61 8 9360 1381
Major grains research infrastructure includes Physical Containment Level 1 (PC1) and PC2 glasshouses adjacent to 2.8 Ha of irrigated and netted field plots, together with storage and office facilities.
Funded through a partnership between Murdoch University, the Department of Primary Industries and Regional Development, Curtin University, and the Grains Research and Development Corporation, the Hub was established to help boost crop productivity and reduce the impact of disease, while improving crop research in Western Australia.
The MindBody Lab is a $1.1 million research and laboratory facility to further cognitive neuroscience and integrate it with psychology, psychophysiology, exercise science, health and rehabilitation research.
It contains dedicated space and equipment for electrophysiological and psychophysiological testing; cognitive testing and training; exercise and physical activity testing and training; neuromuscular testing; and pain-related research.
The facility can be used to understand endurance and performance in elite athletes, balance and mobility in elderly people and perception and pattern recognition in first response emergency service professionals.
Associate Professor Timothy Fairchild
+61 8 9360 2959